Jeffrey D. Bloss, M.D., has been promoted to senior vice president, Medical Affairs Americas, Astellas Scientific and Medical Affairs (ASMA). Dr. Bloss will serve as a member of the Astellas US Management Committee.
Dr. Bloss joined the company in October 2012, and has been responsible for leading the America's Regional Medical Affairs function. He also had direct oversight of the Medical Affairs functions in Canada and Brazil, establishing strong collaborations with other functions throughout the company to optimize medical/scientific value across the product lifecycle.
Prior to joining the company, he was vice president and head of Oncology Global Medical Affairs at GlaxoSmithKline, and he served in various leadership roles at Eli Lilly and Co., Genentech and Onyx Pharmaceuticals.
"Jeff has been a key partner and thought leader to the Global Medical Affairs function since joining Astellas in 2012," said Masao Yoshida, chief executive officer, Astellas US LLC. "We're thrilled to promote Jeff to his new role as SVP of Medical Affairs for the Americas for ASMA."